Automating machining operations is at the top of the list of goals for most manufacturers, as needs and capital expenditure budgets allow.
Good science does not equate to workable manufacturing. This has been a longstanding truth in tissue engineering, a field that has been in limbo between academic R&D and commercialization for its entire decades-long existence.
